India's drug regulator DCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date. In a letter to the Serum Institute of India, Drugs Controller General of India V G Somani said the SII is permitted to apply the shelf life of nine months to unlabelled vials available on hand. ► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTim... ► More Videos @ ETTV - http://economictimes.indiatimes.com/TV ► http://EconomicTimes.com ► For business news on the go, download ET app: https://etapp.onelink.me/tOvY/Economi... Follow ET on: ► Facebook - / economictimes ► Twitter - / economictimes ► LinkedIn - / economictimes ► Instagram - / the_economic_times ► Flipboard - https://flipboard.com/@economictimes